ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,282Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 168

$868K Total Retail Price of All Prescriptions

Rank: 4 out of 168

437 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 437 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 437 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 16,607 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $84 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
ATENOLOL 861 816 1 8
ATORVASTATIN CALCIUM 838 819 2 16
AMLODIPINE BESYLATE 800 773 3 4
LISINOPRIL 653 592 4 2
SIMVASTATIN 564 529 5 1
OMEPRAZOLE 553 547 6 3
METOPROLOL SUCCINATE 519 492 7 12
DIOVAN 456 456 8 50
ISOSORBIDE MONONITRATE ER 426 414 9 64
WARFARIN SODIUM 417 413 10 6
HYDROCHLOROTHIAZIDE 402 381 11 11
FUROSEMIDE 388 384 12 7
ZOLPIDEM TARTRATE 376 371 13 17
LIPITOR 351 340 14 84
NIFEDIPINE ER 340 332 15 82
LEVOTHYROXINE SODIUM 306 298 16 5
METFORMIN HCL 298 270 17 18
METOPROLOL TARTRATE 287 284 18 9
PANTOPRAZOLE SODIUM 198 193 19 74
CLOPIDOGREL 182 177 20 77
PRAVASTATIN SODIUM 175 175 21 37
SOLARAZE 174 171 22 167
PLAVIX 172 172 23 109
ENALAPRIL MALEATE 168 142 24 149
RAMIPRIL 167 159 25 169
NEXIUM 162 159 26 93
LIDODERM 160 160 27 91
CARVEDILOL 144 130 28 66
GLYBURIDE 143 143 R 29 104
LOSARTAN POTASSIUM 142 138 30 53
ALLOPURINOL 139 139 31 45
RANITIDINE HCL 139 138 31 54
DIGOXIN 132 132 33 56
NITROSTAT 123 123 34 143
FLUTICASONE PROPIONATE 122 111 35 30
PAROXETINE HCL 119 119 36 63
DONEPEZIL HCL 118 118 37 29
DOXAZOSIN MESYLATE 112 112 38 144
GLIPIZIDE 105 100 39 133
AZITHROMYCIN 105 99 39 102
IBUPROFEN 105 94 39 97
CITALOPRAM HBR 100 97 42 13
CRESTOR 98 90 43 87
COUMADIN 93 93 44 214
PROAIR HFA 92 78 45 59
TAMSULOSIN HCL 91 91 46 20
TRICOR 91 91 46 217
TRAMADOL HCL 89 89 48 40
ALENDRONATE SODIUM 89 81 48 32
AMIODARONE HCL 85 85 50 221
FINASTERIDE 84 84 51 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 80 52 135
ZETIA 79 74 53 145
HYDRALAZINE HCL 79 79 53 136
ACETAMINOPHEN-CODEINE 78 76 S3 55 120
SERTRALINE HCL 76 72 56 23
MECLIZINE HCL 75 75 57 232
PROPRANOLOL HCL 71 51 58 95
MELOXICAM 69 67 59 111
DIOVAN HCT 69 64 59 241
LEVOXYL 69 69 59 90
POTASSIUM CHLORIDE 61 61 62 83
LABETALOL HCL 56 56 63 202
DILTIAZEM 24HR CD 54 54 64 187
NORVASC 54 54 64 283
FLOVENT HFA 53 44 66 123
PRADAXA 53 53 66 204
ISOSORBIDE DINITRATE 52 52 68 292
CHLORHEXIDINE GLUCONATE 52 52 68 292
TOPROL XL 50 50 70 306
COLCRYS 50 50 70 197
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.